Aaron Royston's Net Worth
$69.1 Million
Who is Aaron Royston?
Aaron Royston has an estimated net worth of $69.1 Million. This is based on reported shares across multiple companies, which include Ventyx Biosciences, Inc., Akero Therapeutics, Inc., Menlo Therapeutics Inc., Elevation Oncology, Inc., and RayzeBio, Inc..
SEC CIK
Aaron Royston's CIK is 0001727703
Past Insider Trading and Trends
2019 was Aaron Royston's most active year for acquiring shares with 4 total transactions. Aaron Royston's most active month to acquire stocks was the month of May. 2021 was Aaron Royston's most active year for disposing of shares, totalling 3 transactions. Aaron Royston's most active month to dispose stocks was the month of May. 2021 saw Aaron Royston paying a total of $15,000,000.00 for 6,605,436 shares, this is the most they've acquired in one year. In 2022 Aaron Royston cashed out on 702,737 shares for a total of $2,897,806.29, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Elevation Oncology, Inc. (ELEV) Snapshot price: $3.095
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -26.94% | -702.74K |
$4.12 | -$2,897,806.29 | 1.91M |
May 25
| |||
Form 4
|
∞
| 2.61M |
$16.00 |
—
| 2.61M |
Jun 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ventyx Biosciences, Inc. (VTYX) Snapshot price: $2.195
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
∞
| 4M |
$16.00 | $5,000,000.00 | 4M |
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Akero Therapeutics, Inc. (AKRO) Snapshot price: $17.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 3.95M |
$16.00 |
—
| 3.95M |
Jun 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Menlo Therapeutics Inc. (VYNE) Snapshot price: $2.11
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
RayzeBio, Inc. (RYZB) Snapshot price: $62.15
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||